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Abstract
The entity of atypical squamous cells of undetermined significance (ASCUS) in The Bethesda System 2001 for reporting cervical
cytology is characterized by equivocal diagnosis, poor reproducibility and debatable management. This retrospective study was done
to analyse the causes of false ASCUS if any and identify the educational needs as part of quality assurance programme. Cervical
smears of all ASCUS cases reported over the one-year period were reviewed by the Cytopathologist. Relevant clinical data was
retrieved. ASCUS was the most common type of abnormality representing 43.0 % cases among 294 abnormal smears reported during
study period. 16.0% cases were found to be non ASCUS on review. The main four causes of over use of ASCUS diagnosis were poor
quality smears and cellular atypia associated with Candida infection, atrophy and squamous metaplasia. Educational measures are
being undertaken to avoid over diagnosis and improve the patient management (Afr J Reprod Health 2011; 15[1]: 111-114).

Résumé
Causes des fausses cellules de l’épithélium atypique d’un diagnostic d’une signification inconnue et le besoin éducatif dans un
Centre Hospitalier Universitaire. L’entité des cellules de l’épithélium atypique d’une signification non déterminée(CEAS) dans le
système Bethesda 2001 destiné à la déclaration de la cytologie cervicale est caractérisée par le diagnostic équivoque, une mauvaise
reproductivité et un traitement discutable. Cette étude rétrospective a été faite pour analyser les causes des fausses CEAS, si cela
existe, et d’identifier les besoins éducatifs comme faisant partie du programme de l’assurance de qualité. Le Cytopathologue a passé
en revue tous les frottis de tous les cas de la CEAS qui ont été déclarés au cours d’une année. Les données cliniques nécessaires ont
été rétablies. La CEAS était l’anomalie la plus commune, ce qui représente 43,0% parmi les 294 frottis anomaux qui ont été déclarés
au cours de la période de l’étude. A la revue, on a découvert que 16,0% n’étaient pas des CEAS. Les quatre causes principales du
suremploi du diagnostic de la CEAS étaient la mauvaise qualité du frottis et l’atypie cellulaire liée à l’infection candidose, l’atrophie
et la métaplasie squameuse. On prend des mesures éducatives pour éviter le surdiagnostic et pour améliorer le traitement de la
patiente (Afr J Reprod Health 2011; 15[1]: 111-114).
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Introduction
The entity of atypical squamous cells of undetermined
significance (ASCUS) in The Bethesda System (TBS)
2001 for reporting cervical cytology (also known as Pap
smears) is characterized by equivocal diagnosis, poor
reproducibility and debatable management.1,2 Therefore it
is a challenge to the pathologist and clinician alike and
stressful for the patient.
Our cytology laboratory is attached to the University
Hospital and receives Pap smears collected in outpatient
departments of our hospital and those sent by clinical
officers,
general
practitioners,
physicians
and
gynecologists from other private hospitals, clinics and
laboratories. All cases are screened initially by the
residents and then reported in consultation with the
faculty (two tier screening).

The present study was done to analyse the causes of false
ASCUS if any and identify the educational needs for the
residents and pathologists as part of quality assurance
programme of our lab. The aim is to propose measures to
improve the efficacy of cervical cytology screening. In
Kenya, there is only opportunistic screening of the
women visiting any out- patient clinic for gynecological
or unrelated conditions and asymptomatic women who
request it.

Methods
The laboratory records of all abnormal Pap smears were
reviewed for the one-year period from January 1, 2009 to
December 31, 2009. Relevant clinical data and follow up
cytology or histology (where available) for all ASCUS
cases was retrieved. No reflex Human Papillomavirus
(HPV) testing is done in our lab. The cytopathologist
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(NK) with experience of 25 years reviewed all the smears
reported as ASCUS.

Results
A total of 6,500 Pap smears were screened during the
study period out of which 294 (4.5%) were reported
abnormal. ASCUS was the most common type of
abnormal pap smear result representing 43.0 % (126)
cases among all abnormal pap smears. The diagnosis of
squamous intraepithelial lesion (SIL) including low grade
SIL and high grade SIL was given in 30.6% (90) and
16.3% (48) cases, respectively. The remaining 10.1%
(30) cases included atypical glandular cells, endometrial
cells in women above 40 years of age and
adenocarcinoma. The ASCUS and SIL (including low
and high grade) ratio was 0.9.
The age range of women with ASCUS diagnosis was
21–63 years (mean age 32 years). Table 1 shows the
distribution of all women with ASCUS diagnosis in
different age groups. The maximum percentage 62.0%
(78 out of 126) of women was in the age group of 30-45
years.
Age range

Number of women (%)

21-29 years
30-45 years
45-55 years
>55 years

18 ((14.0)
78 (62.0)
24 (19.0)
6 (5.0)

In 78.6% (99 out of 126) women no clinical data was
available and this could include both symptomatic and
asymptomatic women for routine pap smears. The
clinical profile was available only in 21.4% (27 out of
126) women with ASCUS diagnosis. The previous
diagnosis of ASCUS, low grade SIL and high grade SIL
was available in 37.0 % (10), 14.8% (4) and 7.4 % (2)
respectively. Past history of LEEP was available in 18.5
% (5) women. In addition 18.5 % (5) had presented with
bleeding and 11.1% (3) had vaginal discharge. Positive
HIV status was mentioned in 30.0% (8 cases) only.
On review of all ASCUS smears none of the above
mentioned significant history appeared to be the cause of
false diagnosis of ASCUS in our series. Only 23.8% (30
out of 126) cases were found to be non ASCUS in
women with no significant past history. These were
diagnosed as normal in 10.0% (3 out of 30) cases,
inflammation with Candida infection in 13.3% (4) cases,
atypia in atrophic smear of 20.0% ( 6) post menopausal,
6.7% (2) post partum women and 16.7% (5) women with
prolonged use of injectable Depo provera. Twenty
percent (6) were considered unsatisfactory due to poor
quality smears and 13.3% (4) were immature squamous
metaplasia. None of the case was upgraded to SIL or
squamous cell carcinoma (SCC).
The follow-up cervical biopsy done within 2 months
of Pap test was available for only 16.0% (20 out of 126)
cases with initial ASCUS result. The biopsy was normal

in 75.0 % (15) cases. CIN 1 was diagnosed in 15.0% (3)
cases. One case each was diagnosed as CIN 3 and SCC.
Pap smears of these cases were confirmed to be ASCUS
on review. There was no follow up biopsy for cases
considered false ASCUS on review.

Discussion
ASCUS is defined as a cellular abnormality that is more
marked than those attributable to reactive changes but
that quantitatively or qualitatively falls short of a
definitive diagnosis of SIL. 2 On follow up ASCUS may
resolve naturally or show an exuberant reactive change or
SIL or SCC on cervical biopsy. The overuse of follow-up
procedures may increase the expense and morbidity of
unnecessary treatment.3
It is particularly a matter of concern in low resource
settings like sub Saharan Africa having high risk
populations with high incidence and prevalence of cancer
cervix and HIV. The problem is further compounded by
the lack of an organized screening programme, lack of
trained cytopathologists and cytoscreeners and lack of
facilities for HPV testing. There is fear among
pathologists of missing an abnormality due to the higher
prevalence of risk factors in this population, the lack of
timely follow-up of abnormal pap smears in view of the
opportunistic screening, the non availability of records or
patient information to enable rescreening of previous pap
smears. 4
All of the above raises important quality assurance
issues. It is currently recommended that laboratory rates
of ASCUS should be less than 5.0 % in low-risk
populations and less than 2 to 3 times the SIL rate in
high-risk populations.3 It was less than one in our study
and well within the recommended range.
High risk patient profile such as HIV positive,
previous ASCUS or antecedent SIL, previously treated
for SIL are more likely to get an ASCUS report. 3
However in our study this did not reflect over diagnosis
of ASCUS. The clinical information was not available in
79.0% women and is the main limitation of this study in
addition to poor follow up information.
Educational sessions for the clinicians are being
conducted and emphasis is given on the critical steps to
obtain good quality smears and importance of adequate
and necessary information on the laboratory requisition
forms. A user friendly request form with a checklist of
the minimum essential data has been developed and is
now in use. Educational session was conducted for
clinicians and other personnel such as nurses and
residents involved in filling the request form.
Presence of air drying, thick poorly spread smear,
hemorrhagic smear, superimposed or crushed nuclei and
dense inflammation obscuring morphology can result in
Upon reevaluation,
over diagnosis of ASCUS. 3,5
ASCUS in 5.0 % (6 out of 126) of our cases should have
been labeled unsatisfactory due to poor quality smears. A
rescreening diagnosis of HSIL or invasive carcinoma for

African Journal of Reproductive Health March 2011; 15(1): 112

Kumar et al

Educational Needs False Atypical Squamous Cells

a smear originally reported as ASCUS is serious error but
was not seen in any of our cases.
Nuclear changes are critical for making the ASCUS
diagnosis and include chromasia, chromatin texture,
nuclear shape and size, and nucleolus. The squamous cell
with nuclear enlargement of 2.5 to 3 times the size of
intermediate squamous cell nucleus is classified as
ASCUS. 2 However visual comparison of nuclear size of
ASCUS from intermediate cell nucleus is imperfect with
low accuracy.6 This is an unavoidable cause of over or
under diagnosis of ASCUS. Different observers give
preference to different criteria and have different
threshold.
The important potential implication of this study is
that the causes of false ASCUS identified in this study
can be avoided with educational measures that are
already in place in our laboratory now. These include
instructional tutorials for the pathologists and residents to
use strict criteria of ASCUS and submitting for a second
review to the cytopathologist for a possible ASCUS
diagnosis in such cases. There is a "learning curve" which
would gradually influence interpretive thresholds.
Archiving of abnormal pap smears in the laboratory is
improved and facilitated by manual recording of
information about all abnormal pap smears and any
follow up biopsy in a separate register. Upgrading of the
laboratory information system to incorporate this
information and facilitate easy retrieval has been
recommended to the information technologist.
In our series 3.0% of ASCUS cases were reassessed
as benign with Candida infection. This can happen
because of the generally unrecognized spectrum of
Candida-associated changes. It needs to be emphasized in
educational sessions that ASCUS of inflammation and
infection such as trichomonas, candida, bacterial
vaginosis or viral infection can cause transient mild
nuclear atypia in cervical cells. This nuclear enlargement
is only twice that of an intermediate squamous-cell
nucleus. In addition other features of inflammation such
as intense orangophilia may be misinterpreted as
keratinizing dysplasia, vacuolated cytoplasm and/or
perinuclear halo may be confused with HPV effect.
Diligent search should be made to identify the organisms.
This guides the clinician to prescribe proper medication
for the infection, without costly follow-up. 3
Atypia in smears showing atrophic pattern due to
various causes (including 6 post menopausal and 2 post
natal women and 5 women with prolonged use of
Depoprovera) led to over diagnosis of ASCUS in 10.3%
(13 out of 126) cases. ASCUS interpretation of reparative
epithelial changes (immature squamous metaplasia) is a
know pitfall and was seen in 13.3% cases. In atrophy and
metaplasia, the nucleus of parabasal cells may be mildly
hyperchromatic with slight increase in nuclear
cytoplasmic ratio (nuclear enlargement less than 3 times
of ICN), but show uniform nuclear spacing, even
chromatin distribution, minimal nuclear pleomorphism
and pseudokoilocytosis.7,8,9

The recommendation in pap smear report on the use
of estrogens in post-menopausal women, treatment of
infection before the repeat smear, the use of reflex HPV
test if affordable (only in women over 20) before referral
to colposcopy can be further helpful.10 In our hospital
most often 6 monthly follow-up with pap smears is
recommended in the absence of HPV testing. In high risk
patients (previously abnormal smear, poor compliance,
immunosuppressed women etc.) the option of immediate
colposcopy and biopsy is considered. 11
To conclude, the main four causes of over use of
ASCUS were poor quality smears, atypia in Candida
associated inflammation, atrophy and immature
squamous metaplasia. This was accompanied by lack of
adequate and necessary information on the request forms
in majority of cases. The educational measures are being
undertaken to increase awareness among pathologists and
clinicians to improve the patient management.
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